SCHEMBL7187280

SCHEMBL7187280

O=C(CCc1cc(O)ccc1O)c1cc(O)ccc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.71
EGFR P00533 2/20 0.55
LCK P06239 2/20 0.55
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA7 P43166 3/20 0.50
CA9 Q16790 3/20 0.50
CA14 Q9ULX7 3/20 0.50
ALOX5 P09917 1/20 0.50
PTGS2 P35354 1/20 0.50
CYP19A1 P11511 1/20 0.47
ALDH1A1 P00352 2/20 0.45
RGS12 O14924 1/20 0.45
MAPT P10636 1/20 0.45
CAMKK2 Q96RR4 1/20 0.45
NOX4 Q9NPH5 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
POLB P06746 1/20 0.45
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL490884 0.81 EGFR (0.57) CHRNA7EGFRLCKCA12CA1
SCHEMBL9748707 0.79 CYP19A1 (0.66) CHRNA7CA12CA1CA2CA7
SCHEMBL4724887 0.79 NPC1 (0.60) CHRNA7ALDH1A1MAPTPOLBNPC1
SCHEMBL25035384 0.78 CHRNA7 (0.57) CHRNA7CA12CA1CA2CA7
SCHEMBL9602694 0.78 ALDH1A1 (0.63) CHRNA7CA12CA1CA2CA7
SCHEMBL6160355 0.78 IAPP (0.53) CHRNA7EGFRLCKALDH1A1POLB
SCHEMBL16324509 0.77 ALDH1A1 (0.56) CHRNA7EGFRLCKCA12CA1
SCHEMBL5083959 0.77 CA12 (0.53) CHRNA7EGFRLCKCA12CA1
SCHEMBL31661754 0.77 CA12 (0.53) CHRNA7EGFRLCKCA12CA1
SCHEMBL6906879 0.77 CYP19A1 (0.58) CHRNA7CYP19A1ALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP claimed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 CHRNA7 4280/4885EGFR 2452/4885LCK 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.